Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.
  • الفعاليات
  • الأخبار
  • الرؤى
  • الحساب
Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

News

Categories

  • الأحدث
  • أشباه الموصلات
  • الأمن السيبراني
  • التكنولوجيا المالية
  • الدفاع
  • الذكاء الاصطناعي والتقنية
  • الرعاية الصحية
  • الروبوتات
  • الزراعة
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الطاقة والتنقل
  • سلسلة الإمداد

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • الأحدث
  • الذكاء الاصطناعي والتقنية
  • الأمن السيبراني
  • أشباه الموصلات
  • الروبوتات
  • التكنولوجيا المالية
  • الطاقة والتنقل
  • الدفاع
  • الرعاية الصحية
  • سلسلة الإمداد
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الزراعة
آخر الأخبار
············

الصفحة 67

Trust in science: A new STAT initiative (opens original source in a new tab)
STAT News

Trust in science: A new STAT initiative

Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver "trusted, tough-minded journalism.'' Little did we know that trust would be…

(opens original source in a new tab)
Rick Berke·19 August 2026
STAT+: Experts scrutinize Huidagene’s disclosures after patient death

الأكثر قراءة

  • 67
Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

(opens original source in a new tab)
STAT News

STAT+: Experts scrutinize Huidagene’s disclosures after patient death

Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout

(opens original source in a new tab)
Elaine Chen·19 August 2026
Clean Energy
(opens original source in a new tab)
CleanTechnica

Famous US Automaker Faces The Music As Million-Dollar Vote Scheme Goes South

A fraud lawsuit against Tesla CEO Elon Musk is moving to the next step, in which class action status will be determined in regards to his pledge to select random voters to receive $1 million each, if they sign petitions circulated by his America PAC. The post Famous US Automaker Faces The Music As Million-Dollar Vote Scheme Goes South appeared first on CleanTechnica.

(opens original source in a new tab)
Tina Casey·19 August 2026
Surprise! London’s tax on polluting cars made everyone much healthier (updated) (opens original source in a new tab)
Electrek

Surprise! London’s tax on polluting cars made everyone much healthier (updated)

The city of London has released a report showing drastic drops in air pollution since it expanded its Ultra Low Emission Zone, an area within the city where polluting vehicles must pay a fee to visit. (Update 8/19/26, original article 5/15/25: A new study shows that children in London have significantly better lung function than before the zone was implemented)

(opens original source in a new tab)
Jameson Dow·19 August 2026
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval (opens original source in a new tab)
STAT News

STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval

A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.

(opens original source in a new tab)
Andrew Joseph·19 August 2026
Tom Gauld on popularity in the lab (opens original source in a new tab)
New Scientist

Tom Gauld on popularity in the lab

Tom Gauld's weekly cartoonTom Gauld's weekly cartoon

(opens original source in a new tab)
Tom Gauld·19 August 2026
The wild, gripping story of the psychedelic secreted by desert toads (opens original source in a new tab)
New Scientist

The wild, gripping story of the psychedelic secreted by desert toads

Kimon de Greef's The Ego Trip chronicles the rise of a potent psychedelic drug, from the toads that secrete it to the man who claimed it has amazing powers. Olivia Goldhill discovers an extraordinary tale

(opens original source in a new tab)
Olivia Goldhill·19 August 2026
This week’s new questions (opens original source in a new tab)
New Scientist

This week’s new questions

Why do humans have a common sense of beauty for things like sunsets, and do other animals share this appreciation? And why can’t we cool water as quickly as we can heat it?

(opens original source in a new tab)
New Scientist·19 August 2026
Twisteddoodles on distribution graphs (with added cats) (opens original source in a new tab)
New Scientist

Twisteddoodles on distribution graphs (with added cats)

This week's cartoon from Twisteddoodles

(opens original source in a new tab)
Twisteddoodles·19 August 2026
Don’t be an archaeologist in a movie if you want to survive (opens original source in a new tab)
New Scientist

Don’t be an archaeologist in a movie if you want to survive

(opens original source in a new tab)
New Scientist·19 August 2026
This sci-fi novel is a riveting tale of an oppressive galactic empire (opens original source in a new tab)
New Scientist

This sci-fi novel is a riveting tale of an oppressive galactic empire

A rich widow, a disillusioned cop and a dim hypersled driver are caught in the machinations of the oppressive party ruling the Decurion Empire in Richard Swan's The Infinite State. Sci-fi columnist Emily H. Wilson enjoys their struggles

(opens original source in a new tab)
Emily H. Wilson·19 August 2026
Are flies following a strategy when they keep hitting windows? Part 4 (opens original source in a new tab)
New Scientist

Are flies following a strategy when they keep hitting windows? Part 4

Answers continue to pour in as New Scientist readers ponder this question, with one reader widening it out to consider dragonflies, and another focusing on cluster flies

(opens original source in a new tab)
New Scientist·19 August 2026
  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.
01

Trust in science: A new STAT initiative

02

STAT+: Experts scrutinize Huidagene’s disclosures after patient death

03

Famous US Automaker Faces The Music As Million-Dollar Vote Scheme Goes South

04

Surprise! London’s tax on polluting cars made everyone much healthier (updated)

05

STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval

Prev
65
66
68
69
70
71
Next
Trust in science: A new STAT initiative
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
Famous US Automaker Faces The Music As Million-Dollar Vote Scheme Goes South
Surprise! London’s tax on polluting cars made everyone much healthier (updated)
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
Tom Gauld on popularity in the lab
Trust in science: A new STAT initiative
STAT+: Experts scrutinize Huidagene’s disclosures after patient death
Famous US Automaker Faces The Music As Million-Dollar Vote Scheme Goes South
Surprise! London’s tax on polluting cars made everyone much healthier (updated)
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
Tom Gauld on popularity in the lab

أسبوع فعاليات الصناعة، يُوصَّل كل جمعة.

بريد إلكتروني قصير واحد. أبرز القصص من المعارض التجارية والمؤتمرات والقمم التي تشكّل الأعمال حول العالم. بلا حشو، بلا بريد عشوائي، إلغاء الاشتراك في أي وقت.